Daniel E. Voth profile photo

Daniel E. Voth

Federal Grant PI High Impact

Department Chairperson

Last publication 2026 Last refreshed 2026-05-22

faculty

Department Chairs, College of Medicine

30 h-index 77 pubs 21,647 cited

Biography and Research Information

OverviewAI-generated summary

Daniel E. Voth's research program focuses on understanding host-pathogen interactions, particularly concerning intracellular bacterial pathogens like *Coxiella burnetii*, the causative agent of Q fever. His work investigates the mechanisms by which these bacteria subvert host cellular processes, such as antioxidant signaling pathways, to establish infection. Voth also explores strategies for combating these infections, including the evaluation of host-directed drugs that can target bacterial growth within human cells. His laboratory employs a range of infection models, including in vitro cell cultures, in vivo animal models, and ex vivo lung tissue models, to gain comprehensive insights into pathogen invasion and host defense.

Metrics

  • h-index: 30
  • Publications: 77
  • Citations: 21,647

Selected Publications

  • Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives (2026)
  • <i>Coxiella burnetii</i> Nine Mile II Δ <i>cbu0533</i> as a suitable laboratory replacement strain (2025)
  • β-glucan-induced monocyte-derived alveolar macrophages confer protection against Mycobacterium tuberculosis 4395 (2025)
  • Control of human Q fever by vaccination: the journey to Q-VAX and beyond (2025)
  • Coxiella burnetii Strains Elicit Distinct Inflammatory Responses in Human Macrophages (2025)
  • The intracellular agent of Q fever, <i>Coxiella burnetii</i> , alters human alveolar macrophage metabolism and mitochondrial physiology (2025)
  • <i>Coxiella burnetii</i> strains elicit distinct inflammatory responses in human macrophages (2025)
  • Guanylate-Binding Proteins Promote Host Defense Against <i>Leishmania major</i> by Balancing iNOS/Arg-1 in Myeloid Cells (2025)
  • Embracing multiple infection models to tackle Q fever: A review of in vitro, in vivo, and lung ex vivo models (2024)
    2 citations DOI OpenAlex
  • Development and validation of systems for genetic manipulation of the Old World tick-borne relapsing fever spirochete, Borrelia duttonii (2024)
    1 citation DOI OpenAlex
  • MicroRNAs Contribute to Host Response to <i>Coxiella burnetii</i> (2022)
    3 citations DOI OpenAlex
  • Editorial: Obligate intracellular bacteria: Evasion and adaptative tactics shaping the host-pathogen interface (2022)
    1 citation DOI OpenAlex
  • Breathe In, Breathe Out: Metabolic Regulation of Lung Macrophages in Host Defense Against Bacterial Infection (2022)
    7 citations DOI OpenAlex
  • MicroRNAs contribute to the host response to <i>Coxiella burnetii</i> (2022)
  • Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells (2021)
    5 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 4 $8,412,384 total

NIH/National Institute of Allergy and Infectious Diseases Contact PI Jun 2024 - Apr 2027

Defining the impact of host-directed drugs on Coxiella burnetii growth in macrophages

National Institute of Allergy and Infectious Diseases $191,250 R21
NIH/NIH Office of the Director Contact PI Sep 2022 - May 2027

Expanding UAMS Research Capacity to Establish a Center for Animal Models of Infection and Disease (CAMID)

NIH Office of the Director $7,975,000 C06
NIH/National Institute of Allergy and Infectious Diseases Contact PI Sep 2020 - Aug 2023

Coxiella burnetii Subversion of Host Nrf2 Antioxidant Signaling- Resubmission

National Institute of Allergy and Infectious Diseases $186,034 R21
NIH/National Institute of General Medical Sciences Contact PI Mar 2000 - Dec 2022

Glycan Expression Analysis using an Odyssey CLx Infrared Imaging System

National Institute of General Medical Sciences $60,100 R01

Grants & Funding

  • Coxiella burnetii Regulation of Macrophage cAMP/PKA Signaling NIH Principal Investigator
  • Defining the impact of host-directed drugs on Coxiella burnetii growth in macrophages UAMS Internal Research Awards Principal Investigator
  • Bacterial cell wall synthesis, shape and septation NIH Principal Investigator
  • Role of the Coxiella burnetii Cryptic Plasmid in Host Cell Parasitism NIH Principal Investigator
  • Manipulation of host signaling by the Q fever agent, Coxiella burnetii American Heart Association (South Central Affiliate) Principal Investigator
  • Coxiella burnetii Subversion of Host Nrf2 Antioxidant Signaling- Resubmission NIH Principal Investigator
  • A Novel Human Lung Infection Platform to Define Staphylococcus aureus Virulence Determinants NIH Principal Investigator
  • Defining Coxiella burnetii Infection of Primary Human Cardiac Cells NIH/Nat. Inst. of Allergy & Infectious Diseases Principal Investigator

Collaboration Network

49 Collaborators 23 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics